‘Passengers’ could have been much more – MyAJC
MyAJC |
‘Passengers’ could have been much more
MyAJC The spaceship is the Avalon, 30 years into a 120-year autopilot journey to the planet colony Homestead II with 5,000 passengers on board, encased in pods that keep them in a state of suspended animation. The pod of Jim Preston (Pratt) malfunctions … Jennifer Lawrence and Chris Pratt are lost in space in the predicable sci-fi thriller ‘Passengers’Baltimore Sun ‘Passengers’ could have been more satisfying as film thriller than romanceThe Mercury News ‘Passengers’ Asks, Are You Willing to Ruin Someone Else’s Life to Save Your Own?PopMatters Parade all 382 news articles » |
The Siasat Daily |
Stem cell ‘living bandage’ for knee injuries trialed in humans
The Siasat Daily The procedure involved taking stem cells, harvested from the patient’s own bone marrow, which were then grown for two weeks before being seeded onto a membrane scaffold that helps to deliver the cells into the injured site. The manufactured Cell … |
|
The Crispr pioneers | Bulletin of the Atomic Scientists
Bulletin of the Atomic Scientists Time may have named Donald Trump the “person of the year,” but the magazine’s short-list for the title includes a group of people who could very well have a … |
Xconomy |
As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends
Xconomy Instead of using the enzyme Cas9 to snip out defective genes inside a cell, the new system uses the enzyme Cpf1. CRISPR–Cpf1 was first described in a paper published in the journal Cell last year, as Xconomy reported. The paper’s authors, including the … Editas licenses new gene-editing tool, raising stakes in drug development raceThe Boston Globe Editas Expands CRISPR Capabilities through New Technology LicensingGenetic Engineering & Biotechnology News Editas Medicine Inks Licensing Deals for CRISPR IPGenomeWeb Bio-IT World all 13 news articles » |
Xconomy |
As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends
Xconomy Instead of using the enzyme Cas9 to snip out defective genes inside a cell, the new system uses the enzyme Cpf1. CRISPR–Cpf1 was first described in a paper published in the journal Cell last year, as Xconomy reported. The paper’s authors, including the … Editas Expands CRISPR Capabilities through New Technology LicensingGenetic Engineering & Biotechnology News Editas licenses new gene-editing tool, raising stakes in drug development raceThe Boston Globe Editas locks down rights to add-on CRISPR techBioPharma Dive Seeking Alpha –Boston Business Journal –GenomeWeb all 13 news articles » |
|
21st Century Cures Act opens up doors for stem cell therapies
Becker’s Orthopedic & Spine With President Barack Obama signing the 21st Century Cures Act into law on Dec. 13, 2016, the field of regenerative medicine and stem cell therapies stands to benefit. The legislation positively affects the field in the following ways: • The FDA may … |